These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32668896)

  • 1. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
    Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
    Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
    Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
    Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study.
    Dehghan A; Rezaei F; Aune D
    Sci Rep; 2023 Aug; 13(1):14229. PubMed ID: 37648706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
    Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country.
    Fahimfar N; Malekzadeh R; Fotouhi A; Mansournia MA; Sarrafzadegan N; Azizi F; Sepanlou SG; Mansourian M; Hadaegh F; Emamian MH; Poustchi H; Talaei M; Pourshams A; Roohafza H; Sharafkhah M; Samavat T; Lotfaliany M; Steyerberg EW; Khalili D
    J Clin Epidemiol; 2022 Jun; 146():1-11. PubMed ID: 34920114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
    Hajifathalian K; Ueda P; Lu Y; Woodward M; Ahmadvand A; Aguilar-Salinas CA; Azizi F; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano D; Msyamboza KP; Oh K; Rodríguez-Artalejo F; Rojas-Martinez R; Shaw JE; Stevens GA; Tolstrup J; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2015 May; 3(5):339-55. PubMed ID: 25819778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the performance of cardiovascular risk prediction tools in rural India: the Rishi Valley Prospective Cohort Study.
    Birhanu MM; Zengin A; Evans RG; Joshi R; Kalyanram K; Kartik K; Danaei G; Barr E; Riddell MA; Suresh O; Srikanth VK; Arabshahi S; Thomas N; Thrift AG
    Eur J Prev Cardiol; 2024 Apr; 31(6):723-731. PubMed ID: 38149975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium.
    Fahimfar N; Khalili D; Sepanlou SG; Malekzadeh R; Azizi F; Mansournia MA; Roohafza H; Emamian MH; Hadaegh F; Poustchi H; Mansourian M; Hashemi H; Sharafkhah M; Pourshams A; Farzadfar F; Steyerberg EW; Fotouhi A
    BMJ Open; 2018 Jul; 8(7):e020303. PubMed ID: 29980541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study.
    Pedroso Camargos A; Barreto S; Brant L; Ribeiro ALP; Dhingra LS; Aminorroaya A; Bittencourt M; Figueiredo RC; Khera R
    Open Heart; 2024 Jun; 11(1):. PubMed ID: 38862252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ten-Year Risk Prediction for Cardiovascular Disease for Malaysian Adults Using the Laboratory-Based and Office-Based (Globorisk) Prediction Model.
    Che Nawi CMNH; Omar MA; Keegan T; Yu YP; Musa KI
    Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the models predicting 10-year risk of cardiovascular diseases in Asia: A systematic review and prediction model meta-analysis.
    Nomali M; Khalili D; Yaseri M; Mansournia MA; Ayati A; Navid H; Nedjat S
    PLoS One; 2023; 18(11):e0292396. PubMed ID: 38032893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.
    Asgari S; Moosaie F; Khalili D; Azizi F; Hadaegh F
    J Transl Med; 2020 Jul; 18(1):267. PubMed ID: 32615996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran.
    Sepanlou SG; Malekzadeh R; Poustchi H; Sharafkhah M; Ghodsi S; Malekzadeh F; Etemadi A; Pourshams A; Pharoah PD; Abnet CC; Brennan P; Boffetta P; Dawsey SM; Kamangar F
    PLoS One; 2015; 10(5):e0126779. PubMed ID: 26011607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Model to Predict 10-Year Risk of Ischemic and Hemorrhagic Stroke and Ischemic Heart Disease Using the China Kadoorie Biobank.
    Yang S; Han Y; Yu C; Guo Y; Pang Y; Sun D; Pei P; Yang L; Chen Y; Du H; Wang H; Massa MS; Bennett D; Clarke R; Chen J; Chen Z; Lv J; Li L;
    Neurology; 2022 Jun; 98(23):e2307-e2317. PubMed ID: 35410902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study.
    Khalili D; Hadaegh F; Soori H; Steyerberg EW; Bozorgmanesh M; Azizi F
    Am J Epidemiol; 2012 Aug; 176(3):177-86. PubMed ID: 22814370
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.